EXHIBIT 10.1
SOLAR3D, INC.
RESTRICTED STOCK GRANT AGREEMENT
This Restricted Stock Grant Agreement (the "AGREEMENT") is made and
entered into as of SEPTEMBER 23, 2013, (the "EFFECTIVE DATE") by and between
Solar3D, Inc., a Delaware corporation (the "COMPANY"), and the person named
below (the "GRANTEE").
GRANTEE: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
------------------------------------
SOCIAL SECURITY NUMBER:
------------------------------------
ADDRESS: ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇
------------------------------------
▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
------------------------------------
TOTAL NUMBER OF SHARES TO BE GRANTED: 20,000,000 (THE "RESTRICTED SHARES")
------------------------------------
1. GRANT OF RESTRICTED SHARES. In consideration for the performance of
services by the Grantee for the Company, whether as a director, officer,
employee or consultant, the Company hereby grants the Restricted Shares to the
Grantee, subject to the conditions of this Agreement. As used in this Agreement,
the term "SHARES" shall mean shares of the Company's common stock, par value
$0.001 per share, which includes the Restricted Shares granted under this
Agreement, and all securities received (i) in replacement of the Shares, (ii) as
a result of stock dividends or stock splits with respect to the Shares, (iii) in
replacement of the Shares in a merger, recapitalization, reorganization or
similar corporate transaction; and (iv) pursuant to an adjustment to the number
of Shares issuable on any vesting date by virtue of Section 1.5 of this
Agreement.
2. VESTING. The Restricted Shares shall vest and be issued to the
Grantee under this Agreement upon the satisfaction of the conditions set forth
in Sections 2.1, 2.2, 2.3 and 2.4 of this Agreement, including attaining the
Company Performance Goals and the other conditions precedent to the issuance of
the eligible Restricted Shares.
2.1 SCHEDULE OF COMPANY PERFORMANCE GOALS. Grantee shall be
eligible for the issuance of Restricted Shares for each Company Performance Goal
attained as follows:
-------------------------- -----------------------------------------------------
RESTRICTED SHARES COMPANY PERFORMANCE GOALS
-------------------------- -----------------------------------------------------
4,000,000 The Company's Market Capitalization exceeds
$10,000,000. Market Capitalization shall mean the
total number of shares of issued and outstanding
common stock, multiplied by the closing trade price
of the Company's stock on the date of determination.
-------------------------- -----------------------------------------------------
-1-
-------------------------- -----------------------------------------------------
6,000,000 The Company's consolidated gross revenue, calculated
in accordance with generally accepted accounting
principles, consistently applied, equals or exceeds
$10,000,000 for the trailing twelve-month period.
-------------------------- -----------------------------------------------------
10,000,000 The Company's consolidated net profit, calculated in
accordance with generally accepted accounting
principles, consistently applied, equals or exceeds
$2,000,000 for the trailing twelve-month period.
-------------------------- -----------------------------------------------------
2.2 VESTING AND ISSUANCE OF ELIGIBLE RESTRICTED SHARES. After
a particular Company Performance Goal has been met, the Restricted Shares
associated with that particular Company Performance Goal shall be eligible for
vesting (the "Eligible Restricted Shares"). The Eligible Restricted Shares shall
vest on a monthly basis, based on the following formula:
5% x Prior Monthly Trade Value
Monthly Number of Vested Shares = ---------------------------------------------
Fair Market Value of the Company's Shares
For the purposes of this Agreement, the Monthly Trade Value of the
Company's Shares shall mean the aggregate sum of the Daily Trade Value in a
calendar month. The Daily Trade Value is defined as the closing trade price of
the Company's Shares multiplied by the daily trade volume. For example, if the
closing trade price was $1.00 and the daily trade volume on that day was 500,000
shares, then the Daily Trade Value for that day would be $500,000. If the
Company's common stock is no longer publicly traded, then the Board of Directors
in good faith shall determine the Monthly Number of Vested Shares.
If the Prior Monthly Trade Value is less than $50,000, then zero
Eligible Restricted Shares shall vest for that month.
The monthly vested Shares, if any, shall be issued to the Grantee
within five (5) business days after the last day of each month.
2.3 FORFEITURE. Grantee shall forfeit all vesting rights for
any Eligible Restricted Shares that have not vested within five (5) years of the
date that the Eligible Restricted Shares were eligible for vesting.
2.4 TERMINATION. If the Grantee's services with the Company,
whether as a director, officer, employee or consultant, terminate for any reason
before the date that the Company Performance Goals have been met, then the
Restricted Shares associated with the unmet Company Performance Goals as of the
date of such termination shall immediately be forfeited as of the date of such
termination. The Eligible Restricted Shares associated with any Company
Performance Goals met prior to the date of such termination shall continue to
vest and be issued to the Grantee in accordance with Sections 2.2 and 2.3 of
this Agreement.
2.5 TITLE TO SHARES. The exact spelling of the name(s) under
which Grantee shall take title to the Shares is:
-2-
---------------------------------------------------------
---------------------------------------------------------
Grantee desires to take title to the Shares as follows:
[ ]Individual, as separate property
[ x ]Husband and wife, as community property
[ ]Joint Tenants
To assign the Shares to a trust, a stock transfer agreement in
a form and substance acceptable to the Company must be completed and executed
and such transfer must comply with applicable federal and state securities laws.
2.6 ADJUSTMENT TO NUMBER OF SHARES. The Company agrees that if
the Fair Market Value of the Company's common stock on the date of Share
issuance is less than the Fair Market Value of the Company's common stock on the
Effective Date, then the number of Shares issuable (assuming all conditions are
satisfied) shall be increased so that the aggregate Fair Market Value of Shares
issuable equals the aggregate Fair Market Value that such number of Shares would
have had on the Effective Date.
2.7 FAIR MARKET VALUE OF SHARES. For the purposes of this
Agreement, "Fair Market Value" shall equal the average of the trailing ten (10)
closing trade prices of the Company's common stock as quoted on the public
securities trading market on which the Company's common stock is then traded;
provided, that if the Company's common stock is not then publicly trading or
quoted, "Fair Market Value" shall be determined by the Company's Board of
Directors in good faith.
3. REPRESENTATIONS AND WARRANTIES OF GRANTEE. Grantee represents and
warrants to the Company that:
3.1 AGREES TO TERMS OF THIS AGREEMENT. Grantee has received a
copy of this Agreement, has read and understands the terms of this Agreement,
and agrees to be bound by its terms and conditions.
3.2 ACCEPTANCE OF SHARES FOR OWN ACCOUNT FOR INVESTMENT.
Grantee is acquiring the Shares for Grantee's own account for investment
purposes only and not with a view to, or for sale in connection with, a
distribution of the Shares within the meaning of the Securities Act of 1933, as
amended (the "Securities Act"). Grantee has no present intention of selling or
otherwise disposing of all or any portion of the Shares.
3.3 ACCESS TO INFORMATION. Grantee has had access to all
information regarding the Company and its present and prospective business,
assets, liabilities and financial condition that Grantee reasonably considers
important in making the decision to acquire the Shares, and Grantee has had
ample opportunity to ask questions of the Company's representatives concerning
such matters and this investment.
-3-
3.4 UNDERSTANDING OF RISKS. Grantee is fully aware of: (i) the
highly speculative nature of the investment in the Shares; (ii) the financial
hazards involved; (iii) the lack of liquidity of the Shares and the restrictions
on transferability of the Shares (e.g., that Grantee may not be able to sell or
dispose of the Shares or use them as collateral for loans); (iv) the
qualifications and backgrounds of the management of the Company; and (v) the tax
consequences of investment in the Shares. Grantee is capable of evaluating the
merits and risks of this investment, has the ability to protect Grantee's own
interests in this transaction and is financially capable of bearing a total loss
of this investment.
3.5 NO GENERAL SOLICITATION. At no time was Grantee presented
with or solicited by any publicly issued or circulated newspaper, mail, radio,
television or other form of general advertising or solicitation in connection
with the offer, sale and issue of the Shares.
4. COMPLIANCE WITH SECURITIES LAWS. Grantee understands and
acknowledges that the Shares have not been registered with the Securities and
Exchange Commission (the "SEC") under the Securities Act and that,
notwithstanding any other provision of this Agreement to the contrary, the
issuance of any Shares is expressly conditioned upon compliance with the
Securities Act and all applicable state securities laws. Grantee agrees to
cooperate with the Company to ensure compliance with such laws.
5. RESTRICTED SECURITIES.
5.1 NO TRANSFERS UNLESS REGISTERED OR EXEMPT. Grantee
understands that Grantee may not transfer any Shares unless such Shares are
registered under the Securities Act and qualified under applicable state
securities laws or unless, in the opinion of counsel to the Company, exemptions
from such registration and qualification requirements are available. Grantee
understands that only the Company may file a registration statement with the SEC
and that the Company is under no obligation to do so with respect to the Shares.
Grantee has also been advised that exemptions from registration and
qualification may not be available or may not permit Grantee to transfer all or
any of the Shares in the amounts or at the times proposed by Grantee.
5.2 SEC RULE 144. In addition, Grantee has been advised that
SEC Rule 144 promulgated under the Securities Act, which permits certain limited
sales of unregistered securities, is not presently available with respect to the
Shares and, in any event, requires that the Shares be held for a minimum of six
months, and in certain cases one (1) year, after they have been acquired, before
they may be resold under Rule 144. Grantee understands that Rule 144 may
indefinitely restrict transfer of the Shares so long as Grantee remains an
"affiliate" of the Company or if "current public information" about the Company
(as defined in Rule 144) is not publicly available.
6. S-8 REGISTRATION.
Upon the issuance of the Restricted Shares, the Company shall
file Form S-8 with the U.S. Securities and Exchange Commission to register the
Restricted Shares.
7. MARKET STANDOFF AGREEMENT. Grantee agrees in connection with any
registration of the Company's securities that, upon the request of the Company
or the underwriters managing any public offering of the Company's securities,
-4-
Grantee shall not sell or otherwise dispose of any Shares without the prior
written consent of the Company or such underwriters, as the case may be, for
such period of time (not to exceed one hundred eighty (180) days) after the
effective date of such registration requested by such underwriters and subject
to all restrictions as the Company or the underwriters may specify. Grantee
further agrees to enter into any agreement reasonably required by the
underwriters to implement the foregoing.
8. COMPANY TAKE-ALONG RIGHT.
8.1 APPROVED SALE. If the Board of Directors of the Company
(the "Board") shall deliver a notice to Grantee (a "SALE EVENT NOTICE") stating
that the Board has approved a sale of all or a portion of the Company (an
"APPROVED SALE") and specifying the name and address of the proposed parties to
such transaction and the consideration payable in connection therewith, Grantee
shall (i) consent to and raise no objections against the Approved Sale or the
process pursuant to which the Approved Sale was arranged, (ii) waive any
dissenter's rights and other similar rights, and (iii) if the Approved Sale is
structured as a sale of securities, agree to sell Grantee's Shares on the terms
and conditions of the Approved Sale which terms and conditions shall treat all
stockholders of the Company equally (on a pro rata basis), except that shares
having a liquidation preference may, if so provided in the documents governing
such shares, receive an amount of consideration equal to such liquidation
preference in addition to the consideration being paid to the holders of Shares
not having a liquidation preference.
Grantee shall take all necessary and desirable lawful actions
as directed by the Board and the stockholders of the Company approving the
Approved Sale in connection with the consummation of any Approved Sale,
including without limitation, the execution of such agreements and such
instruments and other actions reasonably necessary to (A) provide the
representations, warranties, indemnities, covenants, conditions, non-compete
agreements, escrow agreements and other provisions and agreements relating to
such Approved Sale and, (B) effectuate the allocation and distribution of the
aggregate consideration upon the Approved Sale, PROVIDED, that this Section 8
shall not require Grantee to indemnify the purchaser in any Approved Sale for
breaches of the representations, warranties or covenants of the Company or any
other stockholder, except to the extent (x) Grantee is not required to incur
more than its pro rata share of such indemnity obligation (based on the total
consideration to be received by all stockholders that are similarly situated and
hold the same class or series of capital stock) and (y) such indemnity
obligation is provided for and limited to a post-closing escrow or holdback
arrangement of cash or stock paid in connection with the Approved Sale.
8.2 COSTS. Grantee shall bear Grantee's PRO RATA share (based
upon the amount of consideration to be received) of the reasonable costs of any
sale of Shares pursuant to an Approved Sale to the extent such costs are
incurred for the benefit of all selling stockholders of the Company and are not
otherwise paid by the Company or the acquiring party. Costs incurred by Grantee
on Grantee's own behalf shall not be considered costs of the transaction
hereunder.
8.3 SHARE DELIVERY. At the consummation of the Approved Sale,
Grantee shall, if applicable, deliver certificates representing the Shares to be
transferred, duly endorsed for transfer and accompanied by all requisite stock
transfer taxes, if any, and the Shares to be transferred shall be free and clear
of any liens, claims or encumbrances (other than restrictions imposed by this
Exercise Notice) and Grantee shall so represent and warrant.
-5-
8.4 TERMINATION OF COMPANY TAKE-ALONG RIGHT. The Take-Along
Right shall terminate as to the Shares upon the Public Trading Date of the
Shares. For the purposes of this Agreement, the "Public Trading Date" of the
Shares is the date on which the Shares first become freely tradable under the
Securities Act, either pursuant to Rule 144 or another provision of the
Securities Act. The holder of the Shares may apply to have all restrictive
transfer legends removed from the certificates evidencing the Shares, provided
that the request for legend removal is made at such times and in such manner
that removal is accomplished in compliance with the Securities Act and the rules
and regulations promulgated under the Securities Act; and provided further, that
any proposed sale of Shares must comply with all Company policies and
procedures, and with applicable federal, state and local laws.
9.RIGHTS AS A STOCKHOLDER. Subject to the terms and conditions of this
Agreement, Grantee shall have all of the rights of a stockholder of the Company
with respect to the Shares after the Restricted Shares vest and are issuable
until such time as Grantee disposes of the Shares.
10. RESTRICTIVE LEGENDS AND STOP-TRANSFER ORDERS.
10.1 LEGENDS. Grantee understands and agrees that the Company
shall place the legends set forth below or similar legends on any stock
certificate(s) evidencing the Shares, together with any other legends that may
be required by state or federal securities laws, the Company's Certificate of
Incorporation or Bylaws, any other agreement between Grantee and the Company or
any agreement between Grantee and any third party:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE
SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS
PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE
SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION
THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED
TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN
INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY
REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED
TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT
AND ANY APPLICABLE STATE SECURITIES LAWS.
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A
180 DAY MARKET STANDOFF RESTRICTION AS SET FORTH IN A CERTAIN
AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE
SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL
OFFICE OF THE ISSUER. AS A RESULT OF SUCH AGREEMENT, THESE
SHARES MAY NOT BE TRADED PRIOR TO 180 DAYS AFTER THE EFFECTIVE
DATE OF A PUBLIC OFFERING OF THE COMMON STOCK OF THE ISSUER
HEREOF. SUCH RESTRICTION IS BINDING ON TRANSFEREES OF THESE
SHARES.
-6-
10.2 STOP-TRANSFER INSTRUCTIONS. Grantee agrees that, to
ensure compliance with the restrictions imposed by this Agreement, the Company
may issue appropriate "stop-transfer" instructions to its transfer agent, if
any, and if the Company transfers its own securities, it may make appropriate
notations to the same effect in its own records.
10.3 REFUSAL TO TRANSFER. The Company shall not be required
(i) to transfer on its books any Shares that have been sold or otherwise
transferred in violation of any of the provisions of this Agreement or (ii) to
treat as owner of such Shares, or to accord the right to vote or pay dividends
to any purchaser or other transferee to whom such Shares have been so
transferred.
11. TAX CONSEQUENCES. GRANTEE UNDERSTANDS THAT GRANTEE MAY SUFFER
ADVERSE TAX CONSEQUENCES AS A RESULT OF GRANTEE'S ACQUISITION OR DISPOSITION OF
THE SHARES. GRANTEE REPRESENTS (i) THAT GRANTEE HAS CONSULTED WITH A TAX ADVISER
THAT GRANTEE DEEMS ADVISABLE IN CONNECTION WITH THE ACQUISITION OR DISPOSITION
OF THE SHARES AND (ii) THAT GRANTEE IS NOT RELYING ON THE COMPANY FOR ANY TAX
ADVICE.
12. COMPLIANCE WITH LAWS AND REGULATIONS. The issuance and transfer of
the Shares shall be subject to and conditioned upon compliance by the Company
and Grantee with all applicable state and federal laws and regulations and with
all applicable requirements of any stock exchange or automated quotation system
on which the Company's common stock may be listed or quoted at the time of such
issuance or transfer.
13. SUCCESSORS AND ASSIGNS. The Company may assign any of its rights
under this Agreement. This Agreement shall be binding upon and inure to the
benefit of the successors and assigns of the Company. Subject to the
restrictions on transfer herein set forth, this Agreement shall be binding upon
Grantee and Grantee's heirs, executors, administrators, legal representatives,
successors and assigns.
14. GOVERNING LAW; SEVERABILITY. This Agreement shall be governed by
and construed in accordance with the internal laws of the State of Delaware as
such laws are applied to agreements between Delaware residents entered into and
to be performed entirely within Delaware, excluding that body of laws pertaining
to conflict of laws. If any provision of this Agreement is determined by a court
of law to be illegal or unenforceable, then such provision shall be enforced to
the maximum extent possible and the other provisions shall remain fully
effective and enforceable.
15. NOTICES. Any notice required to be given or delivered to the
Company shall be in writing and addressed to the Corporate Secretary of the
Company at its principal corporate offices. Any notice required to be given or
delivered to Grantee shall be in writing and addressed to Grantee at the address
indicated above or to such other address as Grantee may designate in writing
from time to time to the Company. All notices shall be deemed effectively given
upon personal delivery, (i) three (3) days after deposit in the United States
mail by certified or registered mail (return receipt requested), (ii) one (1)
business day after its deposit with any return receipt express courier
(prepaid), or (iii) one (1) business day after transmission by facsimile or
email.
-7-
16. FURTHER INSTRUMENTS. The parties agree to execute such further
instruments and to take such further action as may be reasonably necessary to
carry out the purposes and intent of this Agreement.
17. HEADINGS; COUNTERPARTS. The captions and headings of this Agreement
are included for ease of reference only and shall be disregarded in interpreting
or construing this Agreement. All references herein to Sections shall refer to
Sections of this Agreement. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an
original, and all of which together shall constitute one and the same agreement.
18. ENTIRE AGREEMENT. This Agreement constitutes the entire agreement
and understanding of the parties with respect to the subject matter of this
Agreement, and supersedes all prior understandings and agreements, whether oral
or written, between the parties hereto with respect to the specific subject
matter of this Agreement.
WHEREOF, the Company has caused this Agreement to be executed by its
duly authorized representative and Grantee has executed this Agreement as of the
Effective Date.
SOLAR3D, INC. GRANTEE
By: /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
--------------------------------- ----------------------------------
(Signature)
▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
------------------------------------- ----------------------------------
(Please print name) (Please print name)
DIRECTOR
-------------------------------------
(Please print title)
-8-
SPOUSE CONSENT
The undersigned spouse of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ (the "GRANTEE") has read,
understands, and hereby approves the Restricted Stock Grant Agreement between
Solar3D, Inc., a Delaware corporation (the "COMPANY") and Grantee (the
"AGREEMENT"). In consideration of the Company's granting my spouse the right to
purchase the Shares as set forth in the Agreement, the undersigned hereby agrees
to be irrevocably bound by the Agreement and further agrees that any community
property interest shall similarly be bound by the Agreement. The undersigned
hereby appoints Grantee as my attorney-in-fact with respect to any amendment or
exercise of any rights under the Agreement.
Date: 9/23/2013 ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------- ---------------------------------------
Print Name of Grantee's Spouse
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------------- ---------------------------------------
(Please print name) Signature of Grantee's Spouse
C.E.O. Address:
---------------------------------- ---------------------------------------
(Please print title) ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇
---------------------------------------
▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
---------------------------------------
/_/ Check this box if you do not have a spouse.